Ventricular fibrillation with intracoronary adenosine during fractional flow reserve assessment

Cardiovasc Revasc Med. 2016 Oct-Nov;17(7):487-489. doi: 10.1016/j.carrev.2016.07.004. Epub 2016 Jul 20.

Abstract

Fractional flow reserve (FFR) measurement provides useful hemodynamic assessment of intermediate coronary stenoses affecting long term outcomes. While the gold standard remains intravenous adenosine, intracoronary (IC) bolus administration of adenosine is routinely used in clinical practice because of its ease of use and lower dose providing comparative hyperemia with the most common side effect being a transient atrioventricular block. A 62year old male underwent left heart catheterization after ruling in for non-ST elevation myocardial infarction (NSTEMI). Presenting electrocardiogram (ECG) showed an old left bundle branch block and T-wave inversions in lateral leads (QTc 494ms) with no significant electrolyte abnormalities. Coronary angiography revealed an intermediate lesion in mid left anterior descending coronary artery. FFR assessment with IC adenosine (24μg/mL of normal saline) was performed inducing ventricular fibrillation (VF). He was successfully defibrillated with a single 200J shock and no further arrhythmias were noticed during rest of his hospital stay.

Keywords: Fractional flow reserve; Percutaneous coronary intervention; Ventricular fibrillation.

Publication types

  • Case Reports

MeSH terms

  • Adenosine / administration & dosage
  • Adenosine / adverse effects*
  • Cardiac Catheterization*
  • Coronary Angiography
  • Defibrillators
  • Electric Countershock / instrumentation
  • Electrocardiography
  • Fractional Flow Reserve, Myocardial*
  • Humans
  • Hyperemia / physiopathology
  • Infusions, Intra-Arterial
  • Male
  • Middle Aged
  • Non-ST Elevated Myocardial Infarction / diagnosis*
  • Non-ST Elevated Myocardial Infarction / physiopathology
  • Predictive Value of Tests
  • Vasodilator Agents / administration & dosage
  • Vasodilator Agents / adverse effects*
  • Ventricular Fibrillation / chemically induced*
  • Ventricular Fibrillation / diagnosis
  • Ventricular Fibrillation / therapy

Substances

  • Vasodilator Agents
  • Adenosine